Samsung’s biotech unit debuts in Seoul. Here’s what to know. – U.S. News & World Report
Financial Express |
Samsung's biotech unit debuts in Seoul. Here's what to know.
U.S. News & World Report SEOUL, South Korea (AP) — Samsung Biologics Co., the contract drug making unit of Samsung Group, made its market debut in Seoul on Thursday in South Korea's largest initial public offering in six years. Samsung is looking to biotech to be a new core … Samsung's drug-manufacturing unit goes publicPhys.Org Samsung Biologics Jumps In Debut Trading, Boosted By Trump's WinBarron’s (blog) Samsung BioLogics shares rally on debut as pharma stocks cheer Trump winReuters The Korea Herald –Business Insider –Yahoo Sports –Forbes all 15 news articles » |